Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: FOXFIRE protocol: an open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation Therapy (SIRT) as first-line treatment for patients with unresectable liver-only or liver-dominant metastatic colorectal cancer

Figure 1

Basic clinical trial schema for FOXFIRE clinical trial. Dose modification of oxaliplatin in the Intervention Arm is described in the main text. *Biological agents (e.g. cetuximab or bevacizumab) are permitted from cycle 1 in the control arm or from cycle 7 in the intervention arm.

Back to article page
\